Rocket Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms.
CEOGaurav D. Shah
CEOGaurav D. Shah
Employees299
Employees299
HeadquartersCranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded1999
Founded1999
Employees299
Employees299
RCKT Key Statistics
Market cap674.98M
Market cap674.98M
Price-Earnings ratio-2.39
Price-Earnings ratio-2.39
Dividend yield—
Dividend yield—
Average volume3.06M
Average volume3.06M
High today$6.60
High today$6.60
Low today$6.11
Low today$6.11
Open price$6.35
Open price$6.35
Volume2.08M
Volume2.08M
52 Week high$26.98
52 Week high$26.98
52 Week low$4.55
52 Week low$4.55
Analyst ratings
94%
of 18 ratingsBuy
94.4%
Hold
5.6%
Sell
0%
People also own
Based on the portfolios of people who own RCKT. This list is generated using Robinhood data, and it’s not a recommendation.